No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Sunday, October 26, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Market Analysis

1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer

by TheAdviserMagazine
6 months ago
in Market Analysis
Reading Time: 5 mins read
A A
1 Stock to Buy, 1 Stock to Sell This Week: Meta Platforms, Pfizer
Share on FacebookShare on TwitterShare on LInkedIn


• Tariff headlines, ‘Mag 7’ earnings, U.S. jobs report, and PCE inflation data will be in focus this week.

• Meta is expected to report better-than-feared earnings due to an improving digital ad market, making it an appealing stock to buy.

• Pfizer’s expected earnings dive and sales decline suggest a more cautious approach.

• Looking for more actionable trade ideas? Subscribe here for 50% off InvestingPro!

The stock market ended higher on Friday, with the major averages registering sharp gains for the week driven by hopes for a de-escalation of the U.S.- China trade war.

The rose 2.5% for the week, the jumped 4.6%, while the tech-heavy soared 6.7%.

Source: Investing.com

More volatility could be in store this week as investors continue to assess the outlook for the economy, inflation, interest rates and corporate earnings amid President Donald Trump’s trade war.

Wall Street’s first quarter earnings season hits full swing, with four of the massive ‘Magnificent Seven’ tech stocks set to report their latest results. Microsoft (NASDAQ:) and Meta Platforms (NASDAQ:) report on Wednesday night, while Apple (NASDAQ:) and Amazon (NASDAQ:) are due late Thursday.

Other high-profile companies on the agenda include Qualcomm (NASDAQ:), ExxonMobil (NYSE:), Chevron (NYSE:), Eli Lilly (NYSE:), Pfizer (NYSE:), Coca-Cola (NYSE:), McDonald’s (NYSE:), Starbucks (NASDAQ:), United Parcel Service (NYSE:), Caterpillar (NYSE:), Robinhood (NASDAQ:), PayPal (NASDAQ:), Visa (NYSE:), and Mastercard (NYSE:).

Meanwhile, most important on the economic calendar will be Friday’s U.S. employment report, which is forecast to show the economy added 129,000 positions in April. The unemployment rate is seen holding steady at 4.2%.

Source: Investing.com

Besides the monthly jobs report, there is also important first-quarter GDP data, as well as the core PCE price index, which is the Fed’s favorite inflation gauge.

Regardless of which direction the market goes, below I highlight one stock likely to be in demand and another which could see fresh downside. Remember though, my timeframe is just for the week ahead, Monday, April 28 – Friday, May 2.

Stock To Buy: Meta Platforms

Meta Platforms looks positioned for a strong showing when it reports Q1 earnings this Wednesday after the close at 4:40PM ET. CEO Mark Zuckerberg and CFO Susan Li are scheduled to discuss the results during a 5:00PM ET earnings call.

The improving digital advertising market, coupled with Meta’s ongoing investments in AI and its massive user base across platforms like Facebook, Instagram, Threads, Reels, and WhatsApp, suggest the social media giant may deliver results that exceed tempered expectations.

Market participants foresee a sizable swing in META stock after the print drops, with a possible implied move of 8.3% in either direction.

Source: InvestingPro

While Meta’s growth has decelerated in recent quarters, analysts project a solid 13% year-over-year revenue increase to $41.3 billion, accompanied by an 11% rise in adjusted earnings per share to $5.20.

Despite broader market volatility and concerns over reduced ad spend from Chinese e-commerce firms due to escalating U.S.-China trade tensions, Meta’s diversified revenue streams and expanding global user base provide a buffer.

Moreover, Meta’s strategic investments in artificial intelligence, including new state-of-the-art data centers, position it well for long-term growth.

It is also worth noting that Meta will hold its initial ‘LlamaCon’ event on Tuesday, at which it is expected to highlight open-source advancements through its Llama family of generative AI models.

Source: Investing.com

META stock ended Friday’s session at $547.27, about 26% below its all-time high reached in mid-February. At current levels, the Menlo Park, California-based tech behemoth has a market cap of $1.38 trillion, making it the sixth most valuable company on the U.S. stock exchange.

As InvestingPro points out, Meta boasts a “GREAT” Financial Health Overall Score of 3.22, with particularly strong metrics in Profit (4.49) and Cash Flow (3.74). Analysts are overwhelmingly bullish on Meta, with a Strong Buy consensus recommendation (1.48) and a mean price target of $713.63, suggesting upside potential of 30.4% from current levels.

Be sure to check out InvestingPro to stay in sync with the market trend and what it means for your trading. Subscribe now and position your portfolio one step ahead of everyone else!

Stock to Sell: Pfizer

On the opposite end of the spectrum, Pfizer, the pharmaceutical giant, is bracing for the release of its Q1 financial results on Tuesday at 6:45AM ET. The ‘Big Pharma’ company is grappling with several headwinds, including declining demand for its COVID-19 products and increased competition in its non-COVID portfolio.

Additionally, Pfizer’s recent decision to abandon another obesity drug development program underscores the challenges it faces in replenishing its product pipeline and sustaining long-term growth.

Market participants expect a possible implied move of 4% in either direction in PFE stock after the print drops.

Source: InvestingPro

Analysts project a significant drop in earnings, with EPS expected to fall over 18% to $0.69 per share, and revenue anticipated to decrease by approximately 6% to $14.1 billion.

This pessimistic outlook is largely due to the expiration of the Diovan patent, a reduction in Rasilez/Titrandet demand, and increased competition in the ALTITUDE clinical study.

With limited near-term catalysts to offset these pressures, Pfizer’s stock could face further selling pressure post-earnings. While its dividend yield remains attractive at current price levels, Pfizer’s near-term growth prospects have dimmed considerably.

Source: Investing.com

PFE stock –which fell below $21 for the first time since July 2012 earlier this month– closed at $22.92 on Friday. At current valuations, Pfizer has a market cap of $130 billion. Shares, which are trading below their key moving averages, are down 13.6% in 2025.

As per InvestingPro, Pfizer maintains a “GOOD” Financial Health Overall Score of 2.86, with its strongest component being Profit (3.71), followed by Cash Flow (2.80) and Price Momentum (2.77). Growth is its weakest area at 2.03.

Whether you’re a novice investor or a seasoned trader, leveraging InvestingPro can unlock a world of investment opportunities while minimizing risks amid the challenging market backdrop.

Subscribe now and instantly unlock access to several market-beating features, including:

• ProPicks AI: AI-selected stock winners with proven track record.

• InvestingPro Fair Value: Instantly find out if a stock is underpriced or overvalued.

• Advanced Stock Screener: Search for the best stocks based on hundreds of selected filters, and criteria.

• Top Ideas: See what stocks billionaire investors such as Warren Buffett, Michael Burry, and George Soros are buying.

Disclosure: At the time of writing, I am long on the S&P 500, and the via the SPDR® S&P 500 ETF (SPY), and the Invesco QQQ Trust ETF (QQQ). I am also long on the Invesco Top QQQ ETF (QBIG), and Invesco S&P 500 Equal Weight ETF (RSP).

I regularly rebalance my portfolio of individual stocks and ETFs based on ongoing risk assessment of both the macroeconomic environment and companies’ financials.

The views discussed in this article are solely the opinion of the author and should not be taken as investment advice.

Follow Jesse Cohen on X/Twitter @JesseCohenInv for more stock market analysis and insight.



Source link

Tags: BuyMetaPfizerplatformsSellstockweek
ShareTweetShare
Previous Post

A Trump-induced interest rate cut won’t actually lower mortgage rates

Next Post

Regev seeks to connect Metro to Samaria

Related Posts

edit post
Where We Go Next After NY Climate Week

Where We Go Next After NY Climate Week

by TheAdviserMagazine
October 24, 2025
0

The 2025 New York climate week spurred discussions. What stood out for us was that everyone’s takeaways were rooted in...

edit post
What I’ve Found So Far

What I’ve Found So Far

by TheAdviserMagazine
October 24, 2025
0

Since July, I’ve attended the Hubspot Inbound, Oracle AI World, and SupportLogic’s Enterprise AI for CX conferences. I’ve also been...

edit post
California’s TFAIA Act Revives Conversation On AI Regulations

California’s TFAIA Act Revives Conversation On AI Regulations

by TheAdviserMagazine
October 24, 2025
0

Defying the odds and lobbying pressure, California’s SB 53, known as the Transparency in Frontier Artificial Intelligence Act (TFAIA), is...

edit post
Bitcoin: 2,000 Level Emerges as Key Resistance for Next Leg Higher

Bitcoin: $112,000 Level Emerges as Key Resistance for Next Leg Higher

by TheAdviserMagazine
October 24, 2025
0

Bitcoin holds above $106,000 support, showing signs of recovery within its price channel. A close above $115,000 could confirm a...

edit post
CPI Preview: Inflation Data Looms Amid Shutdown With Fed Decision on the Horizon

CPI Preview: Inflation Data Looms Amid Shutdown With Fed Decision on the Horizon

by TheAdviserMagazine
October 24, 2025
0

As markets await the September (CPI) report, set for release Friday at 8:30 AM ET, investors and policymakers face a...

edit post
Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast

Comprehensive Sodium-Ion Battery Market Analysis: Demand Forecast

by TheAdviserMagazine
October 24, 2025
0

The Sodium-Ion Battery Market is gaining momentum as industries seek sustainable, cost-effective, and resource-abundant alternatives to lithium-ion technology. With sodium...

Next Post
edit post
Regev seeks to connect Metro to Samaria

Regev seeks to connect Metro to Samaria

edit post
Top Wall Street analysts pick these stocks for robust growth potential

Top Wall Street analysts pick these stocks for robust growth potential

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
I Thrift Shop for a Living. Here Are My 8 Best Tips for You.

I Thrift Shop for a Living. Here Are My 8 Best Tips for You.

0
edit post
Yuga Labs Partners With Amazon Games to Launch NFT Game in Otherside

Yuga Labs Partners With Amazon Games to Launch NFT Game in Otherside

0
edit post
What You Need to Know About The Ugly Side of Amazon Subscribe and Save

What You Need to Know About The Ugly Side of Amazon Subscribe and Save

0
edit post
Metals on fire: What’s driving the unstoppable rally in copper, aluminium, and zinc

Metals on fire: What’s driving the unstoppable rally in copper, aluminium, and zinc

0
edit post
Russia’s ‘disposable-goods’ economy gets busier but poorer, and sanctions could trigger a recession

Russia’s ‘disposable-goods’ economy gets busier but poorer, and sanctions could trigger a recession

0
edit post
PG Earnings: All you need to know about Procter & Gamble’s Q1 2026 earnings results

PG Earnings: All you need to know about Procter & Gamble’s Q1 2026 earnings results

0
edit post
Yuga Labs Partners With Amazon Games to Launch NFT Game in Otherside

Yuga Labs Partners With Amazon Games to Launch NFT Game in Otherside

October 26, 2025
edit post
Metals on fire: What’s driving the unstoppable rally in copper, aluminium, and zinc

Metals on fire: What’s driving the unstoppable rally in copper, aluminium, and zinc

October 26, 2025
edit post
Coinbase’s x402 Transactions Rise 10,000% in a Month

Coinbase’s x402 Transactions Rise 10,000% in a Month

October 26, 2025
edit post
American Airlines to resume Israel – US flights

American Airlines to resume Israel – US flights

October 26, 2025
edit post
Real-world ‘Avatar’ in Kenya: Sacred hill turns into a rare-earth battleground for US and China

Real-world ‘Avatar’ in Kenya: Sacred hill turns into a rare-earth battleground for US and China

October 25, 2025
edit post
Trump adds 10% tariff on Canada due to TV ad, but IEEPA doesn’t allow its use against ‘information’

Trump adds 10% tariff on Canada due to TV ad, but IEEPA doesn’t allow its use against ‘information’

October 25, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Yuga Labs Partners With Amazon Games to Launch NFT Game in Otherside
  • Metals on fire: What’s driving the unstoppable rally in copper, aluminium, and zinc
  • Coinbase’s x402 Transactions Rise 10,000% in a Month
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.